
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identifying a typology of men who use anabolic androgenic steroids (AAS)
Renee Zahnow, Jim McVeigh, Geoff Bates, et al.
International Journal of Drug Policy (2018) Vol. 55, pp. 105-112
Open Access | Times Cited: 93
Renee Zahnow, Jim McVeigh, Geoff Bates, et al.
International Journal of Drug Policy (2018) Vol. 55, pp. 105-112
Open Access | Times Cited: 93
Showing 1-25 of 93 citing articles:
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Ingveig Innerdal, et al.
International Journal of Drug Policy (2020) Vol. 95, pp. 102876-102876
Open Access | Times Cited: 77
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Ingveig Innerdal, et al.
International Journal of Drug Policy (2020) Vol. 95, pp. 102876-102876
Open Access | Times Cited: 77
Masculine enhancement as health or pathology: gender and optimisation discourses in health promotion materials on performance and image-enhancing drugs (PIEDs)
Gemma Nourse, Suzanne Fraser, David Moore
Health Sociology Review (2024) Vol. 33, Iss. 3, pp. 289-305
Open Access | Times Cited: 8
Gemma Nourse, Suzanne Fraser, David Moore
Health Sociology Review (2024) Vol. 33, Iss. 3, pp. 289-305
Open Access | Times Cited: 8
Anything but androgens: How image and performance enhancing drug consumers manage body composition and health through off-label use of medicines
Timothy Piatkowski, Kim Akrigg, Luke Cox, et al.
Performance Enhancement & Health (2025), pp. 100329-100329
Open Access | Times Cited: 1
Timothy Piatkowski, Kim Akrigg, Luke Cox, et al.
Performance Enhancement & Health (2025), pp. 100329-100329
Open Access | Times Cited: 1
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Christine Wisløff
Substance Abuse Treatment Prevention and Policy (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 62
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Christine Wisløff
Substance Abuse Treatment Prevention and Policy (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 62
Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access
Orlanda Harvey, Steve Keen, Margarete Parrish, et al.
BMC Public Health (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 61
Orlanda Harvey, Steve Keen, Margarete Parrish, et al.
BMC Public Health (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 61
Exercise Selection and Common Injuries in Fitness Centers: A Systematic Integrative Review and Practical Recommendations
Diego A. Bonilla, Luis Alberto Cardozo, Jorge M. Vélez-Gutiérrez, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12710-12710
Open Access | Times Cited: 33
Diego A. Bonilla, Luis Alberto Cardozo, Jorge M. Vélez-Gutiérrez, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12710-12710
Open Access | Times Cited: 33
Polysubstance use practices among women using anabolic-androgenic steroids (AAS)
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 18
Timothy Piatkowski, Jonathan Robertson, Matthew Dunn
Performance Enhancement & Health (2023) Vol. 11, Iss. 2, pp. 100248-100248
Closed Access | Times Cited: 18
Androgen abuse: Risks and adverse effects in men
Bonnie Grant, Elizabeth Hyams, Rhianna Davies, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 56-70
Open Access | Times Cited: 7
Bonnie Grant, Elizabeth Hyams, Rhianna Davies, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 56-70
Open Access | Times Cited: 7
What is the prevalence of anabolic‐androgenic steroid use among women? A systematic review
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Addiction (2024) Vol. 119, Iss. 12, pp. 2088-2100
Open Access | Times Cited: 7
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Addiction (2024) Vol. 119, Iss. 12, pp. 2088-2100
Open Access | Times Cited: 7
Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy
Mike Salinas, William Floodgate, Robert Ralphs
International Journal of Drug Policy (2019) Vol. 67, pp. 43-51
Open Access | Times Cited: 49
Mike Salinas, William Floodgate, Robert Ralphs
International Journal of Drug Policy (2019) Vol. 67, pp. 43-51
Open Access | Times Cited: 49
“Yay, Another Lady Starting a Log!”: Women’s Fitness Doping and the Gendered Space of an Online Doping Forum
April Henning, Jesper Andreasson
Communication & Sport (2019) Vol. 9, Iss. 6, pp. 988-1007
Open Access | Times Cited: 49
April Henning, Jesper Andreasson
Communication & Sport (2019) Vol. 9, Iss. 6, pp. 988-1007
Open Access | Times Cited: 49
Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Shalender Bhasin, Disa L. Hatfield, Jay R. Hoffman, et al.
Medicine & Science in Sports & Exercise (2021) Vol. 53, Iss. 8, pp. 1778-1794
Open Access | Times Cited: 33
Shalender Bhasin, Disa L. Hatfield, Jay R. Hoffman, et al.
Medicine & Science in Sports & Exercise (2021) Vol. 53, Iss. 8, pp. 1778-1794
Open Access | Times Cited: 33
Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects
Jack B. Ding, Marcus Z. Ng, Steven S. Huang, et al.
Journal of Sports Medicine (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 33
Jack B. Ding, Marcus Z. Ng, Steven S. Huang, et al.
Journal of Sports Medicine (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 33
Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis
Julio Mario Xerfan do Amaral, Andreas Kimergård, Paolo Deluca
BMJ Open (2022) Vol. 12, Iss. 7, pp. e056445-e056445
Open Access | Times Cited: 25
Julio Mario Xerfan do Amaral, Andreas Kimergård, Paolo Deluca
BMJ Open (2022) Vol. 12, Iss. 7, pp. e056445-e056445
Open Access | Times Cited: 25
Severe biventricular cardiomyopathy in both current and former long-term users of anabolic–androgenic steroids
Rang Abdullah, Astrid Bjørnebekk, Lisa E. Hauger, et al.
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 5, pp. 599-608
Open Access | Times Cited: 13
Rang Abdullah, Astrid Bjørnebekk, Lisa E. Hauger, et al.
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 5, pp. 599-608
Open Access | Times Cited: 13
Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia
Katinka van de Ven, Lisa Maher, Handan Wand, et al.
Drug and Alcohol Review (2018) Vol. 37, Iss. 7, pp. 837-846
Closed Access | Times Cited: 41
Katinka van de Ven, Lisa Maher, Handan Wand, et al.
Drug and Alcohol Review (2018) Vol. 37, Iss. 7, pp. 837-846
Closed Access | Times Cited: 41
Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
Kyle Mulrooney, Katinka van de Ven, Jim McVeigh, et al.
Performance Enhancement & Health (2019) Vol. 6, Iss. 3-4, pp. 98-102
Open Access | Times Cited: 36
Kyle Mulrooney, Katinka van de Ven, Jim McVeigh, et al.
Performance Enhancement & Health (2019) Vol. 6, Iss. 3-4, pp. 98-102
Open Access | Times Cited: 36
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, et al.
Substance Abuse Research and Treatment (2020) Vol. 14
Open Access | Times Cited: 36
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, et al.
Substance Abuse Research and Treatment (2020) Vol. 14
Open Access | Times Cited: 36
The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis
Katinka van de Ven, John M. Malouff, Jim McVeigh
Trauma Violence & Abuse (2023) Vol. 25, Iss. 2, pp. 1484-1495
Open Access | Times Cited: 11
Katinka van de Ven, John M. Malouff, Jim McVeigh
Trauma Violence & Abuse (2023) Vol. 25, Iss. 2, pp. 1484-1495
Open Access | Times Cited: 11
Performance and Image Enhancing Drug Use Among Australian Women: The Role of Interpersonal Relationships in Facilitating Use
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 142-159
Open Access | Times Cited: 4
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 142-159
Open Access | Times Cited: 4
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Coal to swole: A survey of anabolic steroid use and muscularity concerns in coalfield areas of Wales
Christopher W. N. Saville, Ieuan Cranswick, David Tod, et al.
Health & Place (2025) Vol. 93, pp. 103456-103456
Open Access
Christopher W. N. Saville, Ieuan Cranswick, David Tod, et al.
Health & Place (2025) Vol. 93, pp. 103456-103456
Open Access
Preventing, producing, or reducing harm? Fitness doping risk and enabling environments
April Henning, Jesper Andreasson
Drugs Education Prevention and Policy (2020) Vol. 29, Iss. 1, pp. 95-104
Open Access | Times Cited: 30
April Henning, Jesper Andreasson
Drugs Education Prevention and Policy (2020) Vol. 29, Iss. 1, pp. 95-104
Open Access | Times Cited: 30
Looking Beyond the Provision of Injecting Equipment to People Who Use Anabolic Androgenic Steroids: Harm Reduction and Behavior Change Goals for UK Policy
Geoff Bates, Jim McVeigh, Conan Leavey
Contemporary Drug Problems (2021) Vol. 48, Iss. 2, pp. 135-150
Open Access | Times Cited: 26
Geoff Bates, Jim McVeigh, Conan Leavey
Contemporary Drug Problems (2021) Vol. 48, Iss. 2, pp. 135-150
Open Access | Times Cited: 26